Led by a world class team, BayMedica is developing efficient and scalable biosynthetic and synthetic chemistry processes to deliver a portfolio of natural cannabinoids including CBC, THCV, CBDV, and CBT as well as novel cannabinoid analogs for life science, pharmaceutical, nutraceutical, cosmetic and animal health applications.
